Acorn Financial Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,824
Closed -$390K 218
2021
Q2
$390K Buy
5,824
+100
+2% +$6.52K 0.12% 165
2021
Q1
$358K Buy
5,724
+1
+0% +$62 0.13% 152
2020
Q4
$357K Buy
5,723
+29
+0.5% +$1.78K 0.14% 155
2020
Q3
$344K Buy
5,694
+126
+2% +$7.58K 0.18% 141
2020
Q2
$328K Sell
5,568
-150
-3% -$8.97K 0.23% 137
2020
Q1
$318K Hold
5,718
0.31% 112
2019
Q4
$368K Buy
+5,718
New +$327K 0.31% 113

Other funds holding BMY

Acorn Financial Advisory Services's BMY Position: Q3 2021 in Review

Acorn Financial Advisory Services sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 5,824 shares — an estimated $390K sold.

Acorn Financial Advisory Services first reported a position in BMY in Q4 2019 and held it in 7 quarters. The position peaked at $390K in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Acorn Financial Advisory Services reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • Acorn Financial Advisory Services sold 5,824 Bristol-Myers Squibb shares in Q3 2021, an estimated $390K.
  • Acorn Financial Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 7 quarters.
  • Acorn Financial Advisory Services's Bristol-Myers Squibb position peaked at $390K in Q2 2021.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Acorn Financial Advisory Services's 13F filing for Q3 2021, filed 15 Nov 2021.